Tamoxifen in women with breast cancer and mammographic density

European Journal of Gynaecological Oncology

Volumn 29, Issue 6, 2008, Pages 598-601

  Meggiorini, M L ^a   Labi, L ^a   Vestri, A R ^a   Porfiri, L M ^a   Savelli, Sara ^a   De Felice, C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Breast cancer; Mammographic density; Tamoxifen

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; COMPUTER ANALYSIS; CONTROLLED STUDY; DIGITAL IMAGING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MONOTHERAPY; QUALITATIVE ANALYSIS; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; TAMOXIFEN;

EID: 56749083523     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Byng J.W., Yaffe M.J., Jong R.A., Shumak R.S., Lockwood G.A., Tritchler D.L. et al.: "Analysis of mammographic density and breast cancer risk from digitized mammograms". Radiographics, 1998, 18, 1587.
2. Kolb T.M., Lichy J., Newhouse J.H.: "Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: analysis of 27,825 patient evaluations". Radiology, 2002, 225, 165.
3. Wolfe J.N.: "Risk for breast cancer development determined by mammographic parenchymal pattern". Cancer, 1976, 37, 2486.
4. Cuzick J., Warwick J., Pinney E., Warren R.M., Duffy S.W.: "Tamoxifen and breast density in women at increased risk of breast cancer". J. Natl. Cancer Inst., 2004, 96, 621.
5. Boyd N.F., Byng J.W., Jong R.A., Fishell E.K., Little L.E., Miller A.B. et al.: "Quantitative classification of mammografic densities and breast cancer risk: results from Canadian National Breast Screening Study". J. Natl. Cancer Inst., 1995, 87, 670.
6. Stone J., Dite G.S., Gunasekara A., English D.R., McCredie M.R., Giles G.G. et al.: "The hereditability of mammographically dense and nondense breast tissue". Cancer Epidemiol. Biomarkers Prev., 2006, 15, 612.
7. El-Bastawissi A.Y., White E., Mandelson M.T., Taplin S.H.: "Reproductive and hormonal factors associated with mammographic breast density by age (United States)". Cancer causes Control., 2000, 11, 955.
8. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet, 1998, 351, 1451.
9. Fisher B., Costantino J.P., Wickerham D.L., Redmond C.K., Kavanah M., Cronin W.M. et al.: "Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study". J. Natl. Cancer Inst., 1998, 90, 1371.
10. Veronesi U., Maisonneuve P., Costa A., Sacchini V., Maltoni C., Robertson C. et al.: "Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study". Lancet, 1998, 352, 93.
11. Brisson J., Brisson B., Coté G., Maunsell E., Bérubé S., Robert J.: "Tamoxifen and mammographic breast densities". Cancer Epidemiol. Biomark Prev., 2000, 9, 911.
12. Marugg R.C., van der Mooren M.J., Hendriks J.H., Rolland R., Ruija S.H.: "Mammographic changes in postmenopausal women on hormonal replacement therapy". Eur. Radiol., 1997, 7, 749.
13. Chow C.K., Venzon D., Jones E.C., Premkumar A., O'Shaughnessy J., Zujewski J.: "Effect of tamoxifen on mammographic density". Cancer Epidemiol. Biomarkers Prev., 2000, 9, 917.
14. Prevrhal S., Sheperd J.A., Smith-Bindman R., Cummings S.R., Kerlikowske K.: "Accuracy of mammographic breast density analysis: results of formal operator training". Cancer Epidemiology, Biomarkers and Prevention, 2002, 11, 1389.
15. Friedenreich C., Bryant H., Alexander F., Hugh J., Danyluk J., Page D.: "Risk factors for benign proliferative breast disease". Int. J. Epidemiol., 2000, 29, 637.